ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.
ZYUS has raised $505K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.
ZYUS's investors include Keyhorse Capital.
ZYUS is headquartered in Saskatoon, Canada.
ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.
ZYUS is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ZYUS — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/zyus. Accessed August 14, 2026.
VCBacked. (2026). ZYUS — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/zyus
{{cite web |title=ZYUS — Funding & Investors |url=https://www.vcbacked.co/company/zyus |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated